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Abstract
Introduction: Prenatal cocaine exposure (PCE) is associated 
with neurobehavioral problems during childhood and adolescen-
ce. Early activation of the inflammatory response may contribute 
to such changes. Our aim was to compare inflammatory markers 
(IL-6 and IL-10) both in umbilical cord blood and in maternal 
peripheral blood at delivery between newborns with history of 
crack/cocaine exposure in utero and non-exposed newborns.
Methods: In this cross-sectional study, 57 newborns with a his-
tory of crack/cocaine exposure in utero (EN) and 99 non-expo-
sed newborns (NEN) were compared for IL-6 and IL-10 levels. 
Sociodemographic and perinatal data, maternal psychopatholo-
gy, consumption of nicotine and other substances were systema-
tically collected in cases and controls.
Results: After adjusting for potential confounders, mean IL-6 
was significantly higher in EN than in NEN (10,208.54, 95% 
confidence interval [95%CI] 1,328.54-19,088.55 vs. 2,323.03, 
95%CI 1,484.64-3,161.21; p = 0.007; generalized linear mo-
del [GLM]). Mean IL-10 was also significantly higher in EN than 
in NEN (432.22, 95%CI 51.44-812.88 vs. 75.52, 95%CI 5.64-
145.39, p = 0.014; GLM). Adjusted postpartum measures of IL-6 
were significantly higher in mothers with a history of crack/cocai-
ne use (25,160.05, 95%CI 10,958.15-39,361.99 vs. 8,902.14, 
95%CI 5,774.97-12,029.32; p = 0.007; GLM), with no significant 
differences for IL-10. There was no correlation between mater-
nal and neonatal cytokine levels (Spearman test, p ≥ 0.28 for all 
measures). 
Conclusions: IL-6 and IL-10 might be early biomarkers of PCE 
in newborns. These findings could help to elucidate neurobiologi-
cal pathways underlying neurodevelopmental changes and broa-
den the range of possibilities for early intervention.
Keywords: Cytokines, pregnancy, crack cocaine, umbilical cord 
blood, newborn, interleukins.
Resumo
Introdução: A exposição pré-natal à cocaína está associada a 
problemas neurocomportamentais durante a infância e adoles-
cência. A ativação precoce da resposta inflamatória pode contri-
buir para tais alterações. Nosso objetivo foi comparar marcadores 
inflamatórios (IL-6 e IL-10) no sangue do cordão umbilical e no 
sangue periférico materno na hora do parto, entre recém-nasci-
dos expostos ao crack intraútero e recém-nascidos não expostos.
Métodos: Neste estudo transversal, 57 recém-nascidos expos-
tos ao crack intraútero (RNE) e 99 recém-nascidos não expostos 
(RNNE) foram comparados quanto aos níveis de IL-6 e IL-10. 
Dados sociodemográficos e perinatais, psicopatologia materna, 
consumo de nicotina e outras substâncias foram sistematica-
mente coletados em casos e controles.
Resultados: Após o ajuste para potenciais confundidores, a mé-
dia de IL-6 foi significativamente maior nos RNE em comparação 
aos RNNE [10.208,54, intervalo de confiança (IC95%) 1.328,54-
19.088,55 versus 2.323,03, IC95% 1.484,64-3.161,21; p = 
0,007; modelo linear generalizado (MLG)]. A média ajustada de 
IL-10 foi significativamente maior nos RNE do que nos RNNE 
(432,2189, IC95% 51,44-812,88 versus 75,52, IC95% 5,64-
145,39, p = 0,014; MLG). Medidas pós-parto ajustadas de IL-6 
foram significativamente maiores nas mães que usaram de cra-
ck/cocaína (25.160,05, IC95% 10.958,15-39.361,99 versus 
8.902,14, IC95% 5.774,97-12.029,32; p = 0,007; MLG), sem 
diferenças significativas para IL-10. Não houve correlação entre 
níveis maternos e neonatais de citocinas (teste de Spearman, p 
≥ 0,28 para todas as medidas).
Conclusões: IL-6 e IL-10 podem ser biomarcadores precoces 
da exposição pré-natal a cocaína em recém-nascidos. Esses re-
sultados podem ajudar a elucidar as vias neurobiológicas subja-
centes a alterações do desenvolvimento e aumentar a gama de 
possibilidades para intervenção precoce.
Descritores: Cocaína crack, interleucinas, recém-nascido, 
gestação.
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Introduction
Prenatal cocaine exposure (PCE) is considered a marker 
for potential development of neurobehavioral problems 
soon after delivery and during childhood/adolescence.1-3 
The harmful effects of intrauterine cocaine exposure 
are not restricted to mental illness. Changes in the 
cardiovascular system have been reported in studies using 
animal models.4 In humans, changes have been observed 
in the neuroendocrine system and metabolic processes, 
with increased weight gain and childhood obesity.5,6 Taken 
together, these data suggest a hypothesis that cocaine 
exposure can have systemic effects. Notwithstanding, the 
pathways underlying these systemic effects in exposed 
newborns remain uncertain. One possible explanation that 
is consistent with other conditions7-14 is early activation of 
the inflammatory response.
Studies using neurobiological markers have suggested 
that cocaine dependence is a chronic stress state.15 For 
example, Fox et al.16 compared 28 adults with cocaine 
dependence to 27 social drinkers and demonstrated 
an elevated inflammatory state, as measured by 
interleukin-10 (IL-10), among other factors. Another 
report found higher levels of IL-1β, TNF-α, and IL-10 in 
the circulation of 53 male crack/cocaine addicts than in 
50 controls.17
Cocaine and its metabolites readily cross the placenta, 
reaching fetal tissues at high concentrations18,19 and 
deregulating fetal homeostasis. A study of the effects 
of PCE on infant hypothalamic-pituitary-adrenal (HPA) 
axis activity and reactivity at 7 months of infant age 
revealed that exposed infants had a high amplitude 
trajectory of cortisol reactivity compared to non-cocaine-
exposed infants.20 Sustained stress triggers a series of 
changes in cytokines. Chronic stress leads to activation 
of the HPA axis, sympathetic nervous system axis, and 
vagus fibers, provoking secretion of glucocorticoids, 
catecholamines, and acetylcholine, thereby disturbing 
cytokine homeostasis.14
It is difficult to distinguish which effects during child 
and adolescent development might be due to PCE and 
which may be due to other adverse conditions. Cocaine-
exposed infants are at higher levels of environmental 
risk and experience unstable caregiving.21 This highlights 
the importance of identifying neurobiological markers 
closer in time to intrauterine exposure. Studies focusing 
specifically on crack/cocaine – or cocaine – exposure 
and cytokines in newborns are scarce. Only one study 
exists, but cytokine levels were not its primary outcome 
measure and the sample size was small (five exposed 
infants and five controls).22
It is known that the neonatal immune system 
is immature relative to the adult immune system.23 
Specifically, anti-inflammatory Th2 response 
predominates, which is probably a consequence of the 
gestational immunosuppression that is necessary to 
maintain the fetus without it being rejected as a foreign 
body.24 There is also a relative absence of IL-12 production 
until the end of infancy, favoring Th2 response.23 During 
pregnancy, a dynamic and delicate balance between 
inflammatory and anti-inflammatory cytokines is 
expected, to protect growth and development of both 
fetus and placenta.24
Given the close relationship between cocaine 
exposure and inflammatory response, the objective 
of this study is to evaluate markers of inflammation 
(IL-6 and IL-10) in newborns with a history of crack/
cocaine exposure in utero (exposed newborns, EN) and 
to compare them with non-exposed newborns (NEN), 
measuring these markers in umbilical cord blood (UCB). 
This strategy makes it possible to identify biomarkers 
very early in the neurodevelopment process, before 
exposure to other external adverse conditions has 
occurred. The hypothesis is that greater activation 
of the inflammatory response will be observed in the 
newborns with a history of crack/cocaine exposure in 
utero. A secondary objective is to evaluate the same 
markers in the mothers of these newborns during the 
postpartum period.
Materials and methods
Data were collected at the Hospital de Clínicas de 
Porto Alegre (HCPA) and the Hospital Materno Infantil 
Presidente Vargas (HMIPV), both in the city of Porto 
Alegre, Brazil, from January 2012 to September 2013. 
Both facilities are teaching hospitals as well as centers 
of excellence for high-risk pregnancies. All mothers 
provided written informed consent for participation, 
and the project was approved by the Research Ethics 
Committees of both hospitals.
Study design and sample
This was a cross-sectional study. The factor under 
study was history of intrauterine exposure to crack/
cocaine and the outcome measures were serum levels 
of the cytokines interleukin (IL)-6 and IL-10 in UCB. 
A secondary outcome was measurement of the same 
markers assayed in the serum of these newborns’ 
mothers.
Mother/newborn dyads with a history of crack/
cocaine exposure underwent consecutive sampling 
at HMIPV. Mothers were questioned about use of 
substances of abuse at admittance to the hospital. 
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During the study period, 2,228 births took place at 
HMIPV, and 105 mothers (4.7%) were identified as 
having a history of crack/cocaine use. Sixty-two 
(59%) of these 105 mothers were invited to take part 
in the study and we ultimately analyzed the UCB of 
57 newborn infants (54%). The losses occurred were 
due to a variety of reasons, including refusal to take 
part, no report of past crack/cocaine use at the time 
of delivery, and absence of the technical conditions 
necessary for UCB collection.
To ascertain the profile of the pregnant crack/
cocaine users who were not included in the sample 
(n = 43; 41%), we used medical records to compare 
participants and non-participants in terms of maternal 
age, educational attainment, ethnicity, presence of a 
partner, prenatal treatment status, mode of delivery, 
and presence of infectious diseases (hepatitis C, syphilis, 
and/or HIV). We also compared Apgar scores at 1 and 5 
minutes, newborn weight, and gestational age (GA) at 
neonatal examination. Newborn weight was significantly 
lower for the infants of mothers who did not participate 
in the study (2,653.46 vs. 2,878.09 g, p = 0.02), as 
were GA (37.30 [standard deviation {SD} = 2.50] vs. 
38.64 [SD = 2.4] weeks, p = 0.02) and prenatal care 
attendance (p = 0.02), with no other significant inter-
group differences (data available upon request).
The control sample of newborns and mothers without 
a history of cocaine exposure was recruited from a 
group of pregnant women who participated in the HCPA 
umbilical cord and placental blood bank project (Banco 
de Sangue de Cordão Umbilical e Placentário, BSCUP). 
During the study period, 6,312 births took place at the 
HCPA. Of this total, 1,050 pregnant women (16.6%) 
were screened for inclusion using a systematic approach 
(Monday through Friday, from 08:00 to 23:00). The 
Foundation for the Accreditation of Cellular Therapy 
(FACT) criteria25 establish technical regulations for the 
operation of laboratories that process hematopoietic 
stem cells (HSC) from bone marrow and peripheral 
blood and for umbilical cord and placental blood banks. 
According to these criteria, 770 (73.3%) of the women 
screened were eligible for data collection, but the 
umbilical cords of 112 (14.5%) of the 770 eligible women 
were rejected by the BSCUP due to low cellularity and/
or low blood volume. These mothers and umbilical cords 
were eligible for use in our control group. Rejected bags 
were sent to the laboratory where the present study 
was underway for processing and storage. Of the 112 
potential participants, 99 (88.3%) were actually enrolled 
on the study as controls. Losses were due to refusal to 
participate in the survey or because the mother and 
newborn had been discharged from the hospital before 
the research team could invite them to participate.
In order to verify the representativeness of the 
mothers included in the control group we randomly 
selected 68 (10.3%) pregnant women whose UCB 
had been collected during the study period and kept 
at the BSCUP and reviewed their medical records. We 
compared the age, ethnicity, prenatal care, and mode of 
delivery of these women to those of mothers included in 
the study control group. We also compared these groups 
in terms of infant sex, need for hospitalization, Apgar 
scores at 1 and 5 minutes, birth weight, GA at neonatal 
examination, and classification of size for GA. There 
were significant differences in newborn weight (3,144.79 
[SD = 438.39] g in the study controls vs. 3,357.35 
[SD = 418.87] g in other donors; p = 0.002) and GA at 
neonatal examination (38.86 [SD = 1.24] weeks in study 
newborns vs. 39.26 [SD = 1.15] weeks among newborns 
not included; p = 0.04). No other significant differences 
were found (data available upon request).
The inclusion criteria for the mothers in the case 
group were history of crack/cocaine use and age 18-45 
years, and exclusion criteria were inability to understand 
and complete the neuropsychiatric questionnaires in 
the immediate postpartum period. The inclusion and 
exclusion criteria for controls were based on the FACT 
criteria25 (Foundation for the Accreditation of Cellular 
Therapy, 2013). All mothers included in the control 
group were confirmed as non-drug users by their history 
and urinary tests (Bioeasy® cocainetest, Alere™, Brazil).
Instruments and variables
The independent variable was a history of crack/
cocaine use during pregnancy. Potential confounders 
were: maternal intelligence quotient (IQ), maternal 
psychopathology, use of other psychoactive substances, 
and demographic and perinatal data. Maternal IQ was 
estimated using the cube and vocabulary subtests of the 
Wechsler Adult Intelligence Scale, 3rd edition (WAIS-
III).26,27 Maternal psychopathology was assessed using 
the Mini International Neuropsychiatric Interview (MINI), 
Brazilian version 5.0.0/ Diagnostic and Statistical Manual 
of Mental Disorders, 4th edition (DSM-IV)/Current.28 
Use of psychoactive substances was evaluated with 
the Alcohol, Smoking and Substance Involvement 
Screening Test (ASSIST),29 as previously used by our 
group.30 By taking these measures, we were able to 
evaluate substance use in the 3 months prior to delivery. 
Socioeconomic level was assessed using criteria set 
forth by Associação Brasileira de Anunciantes (ABA) and 
Associação Brasileira de Institutos de Pesquisa de Mercado 
(ABIPEME), and dichotomized into high socioeconomic 
status (classes A and B) or low socioeconomic status 
(classes C, D, and E).31 Age, self-reported ethnicity, 
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evaluated using generalized linear model (GLM) analyses 
(gamma distribution), and confounders were chosen 
for investigation on the basis of a statistical criterion 
(association with both study factor and outcome measure 
at a significance level of p ≤ 0.2). Confounders that met 
this statistical criterion were entered into the model 
together with each outcome variable. The significance 
level was set at p ≤ 0.05. Data were processed and 
analyzed using PASW Statistics 18.0.
Results
The sample comprised 57 newborns with a history of 
prenatal crack/cocaine exposure and 99 with no history 
of exposure. Table 1 lists a selection of characteristics of 
the newborns and their mothers. Unadjusted IL levels 
(median [minimum and maximum] and mean [SD]) are 
displayed in Table 1. There were no reports of use of 
intravenous drugs, club drugs, or hallucinogens.
Main outcome variable: IL levels in UCB
In the GLM analyses for IL-6, results were adjusted for 
intensity of alcohol, tobacco, and cannabis use in the last 
3 months before delivery, maternal ethnicity, presence 
of any maternal psychopathology, and 5-minute Apgar 
score. Adjusted mean IL-6 was significantly higher in 
newborns with a history of crack/cocaine exposure in 
utero (10,208.54, 95%CI 1,328.54-19,088.55) than 
in non-exposed newborns (2,323.03, 95%CI 1,484.64-
3,161.21; p = 0.007), as shown in Figure 1. Besides 
history of crack/cocaine exposure, the following variables 
were also associated with significant differences in IL-6 
levels: 5-minute Apgar score (p < 0.001), cannabis use 
(p = 0.01), and ethnicity (p = 0.004). For GLM analysis 
of IL-10, results were adjusted for intensity of alcohol, 
tobacco, and cannabis use in the last 3 months before 
delivery, maternal ethnicity, presence of any maternal 
psychopathology, 5-minute Apgar score, infant weight, 
maternal infectious disease (HIV, syphilis, and/or 
hepatitis C), and educational attainment. Adjusted 
mean IL-10 was significantly higher in newborns with 
a history of crack/cocaine exposure in utero (432.22, 
95%CI 51.44-812.88) in comparison to non-exposed 
newborns (75.52, 95%CI 5.64-145.39, p = 0.014), as 
shown in Figure 2. In addition to history of crack/cocaine 
exposure, 5-minute Apgar score also contributed to the 
IL-10 model (95%CI -0.55 to -0.01, p = 0.042).
There were no correlations between IL-6 and IL-10 
levels in maternal serum or in UCB plasma (all p ≥ 0.28; 
Spearman correlation), whether for inter-group or intra-
group comparisons. However, there was a significant 
marital status, and other sociodemographic variables 
were systematically collected using a standard form. 
Ethnicity was dichotomized as non-white or white. The 
following neonatal variables were obtained by review of 
medical records: weight, 1 and 5 minute Apgar scores, 
GA at neonatal examination, sex, need for hospitalization, 
and GA classification. Data on mothers’ clinical status 
(syphilis, HIV, and/or hepatitis C), mode of delivery, and 
prenatal care were also collected from medical records. 
The outcome measures level of IL-6 and level of IL-10 in 
UCB and maternal blood were collected and assayed as 
described below.
Blood collection and processing
Total blood (10 mL) samples were collected by 
venipuncture into an anticoagulant-free vacuum tube. 
Immediately after collection, blood samples were 
centrifuged at 4000 rpm/min for 10 min and serum 
(from patients and controls) or plasma (from newborns) 
was aliquoted, labeled, and stored at -80 °C until the 
time of testing.
Cytokine measurement
Cytokine concentrations were determined via 
flow cytometry using the BD™ Cytometric Bead Array 
(CBA), Human IL-6, and IL-10 Enhanced Sensitivity 
Flex Set (BD Biosciences, San Diego, CA, USA). Sample 
processing and data analysis were performed according 
to the manufacturer’s instructions. Briefly, homogenate 
samples and standard curves ranging from 274 to 
200,000 fg/mL of each cytokine were incubated with the 
three cytokine capture beads for 2 h, then the Human 
Detection Reagent was added and incubated for another 
2 h. The Enhanced Sensitivity Detection Reagent was 
washed twice and then incubated for 1 h. Subsequently, 
samples were washed and sample data acquired using 
a FACSCalibur flow cytometer (BD Biosciences, San 
Diego, CA, USA). All incubations were performed at 
room temperature, protected from light. Results were 
generated in graphical and tabular form using BD CBA 
FCAP Array™ Software v.3 (BD Biosciences, San Diego, 
CA, USA) and expressed as fg/mL.
Statistical analysis
Normally distributed categorical and quantitative 
variables were analyzed with the chi-square test and 
Student’s t test for independent samples respectively. 
When distribution was not normal, the Mann-Whitney 
U test was used instead and values were expressed as 
medians and ranges. The main outcome measure was 
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Table 1 - Sociodemographic data, clinical characteristics and IL levels of pregnant crack/cocaine users and their newborns in 
comparison to a control group
Infant variables Cases (n = 57) Controls (n = 99) p
Weight (g), mean (SD) 2,882.15 (473.32) 3,144.80 (439.39) 0.001
1-minute Apgar, mean (SD) 7.8 (2.12) 8.41 (1.31) 0.06
5-minute Apgar, mean (SD) 8.94 (1.24) 9.38 (0.74) 0.007
Gestational age, weeks (estimated at neonatal examination), mean (SD) 38.58 (2.06) 38.86 (1.24) 0.37
Male sex, n (%) 28 (50.9) 46 (46.5) 0.72
Need for hospitalization, n (%) 36 (67.9) 15 (15.5) < 0.001
Classification for gestational age, n (%)
Adequate 43 (87.8) 75 (77.3)
Small 4 (8.2) 16 (16.5) 0.31
Large 2 (4.1) 6 (6.2)
Maternal variables Cases (n = 57) Controls (n = 99) p
Ethnicity, n (%)
White 17 (32.1) 74 (76.3) < 0.001
Non-white 36 (67.9) 23 (23.7)
Age (years), mean (SD) 27.00 (5.76) 26.17 (5.87) 0.39
IQ, mean (SD) 77.39 (8.75) 84.17 (9.59) < 0.001
Socioeconomic status, n (%)
High (class A or B) 6 (11.8) 18 (18.8) 0.19
Low (class C, D, or E) 45 (88.2) 78 (81.3)
Educational attainment, n (%)
Some primary, completed primary, or some secondary education 39 (81.3) 51 (53.1)
Completed secondary, some higher, or completed higher education 9 (18.8) 45 (53.1) 0.002
Prenatal care, n (%)* 36 (73.5) 99 (100) < 0.001
Presence of infectious diseases, n (%)* (syphilis, HIV, and/or hepatitis C) 26 (46.4) 0 < 0.001
Mode of delivery (Cesarean delivery), n (%) 19 (35.2) 34 (35.1) 1.00
Marital status (married/cohabiting), n (%)* 29 (50.9) 94 (94.9) < 0.001
Drug use by mothers during pregnancy - ASSIST total score, median 
and range† Cases Controls
Total score for nicotine‡ (cases, n = 32; controls, n = 22) 17.50 (0-31) 0.00 (0-39) < 0.001
Total score for alcohol‡ (cases, n = 28; controls, n = 33) 6.00 (0-33) 0.00 (0-13) < 0.001
Total score for cannabis‡ (cases, n = 26; controls, n = 26) 0.00 (0-25) - -
Substance use in the last 3 months prior to delivery, n (%)
Nicotine Cases (n = 32) Controls (n = 22)
Daily/almost every day 22 (68.75) 5 (22.7) < 0.001
Weekly 1 (0.03) -
Monthly 4 (0.13) -
Once or twice 2 (0.06) 17 (77.3)
Never 3 (0.09) -
Alcohol Cases (n = 28) Controls (n = 33)
Daily/almost every day 2 (7.14) - < 0.001
Weekly 10 (35.70) -
Monthly 3 (10.70) -
Once or twice 4 (14.30) 5 (15.20)
Never 9 (32.10) 28 (84.80)
Crack/cocaine Cases (n = 32) Controls (n = 32)
Daily/almost every day 9 (28.1) - -
Weekly 13 (40.6) - -
Monthly 3 (9.4) - -
Once or twice 1 (3.1) - -
Never 6 (10.5) - -
Continued on next page
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sex did make a significant contribution to the IL-10 model 
(Wald = 18.42, p ≤ 0.001), while the predictor variable, 
history of exposure to crack/cocaine during pregnancy and 
the confounder 5-minute Apgar score, remained significant 
(data available upon request).
Secondary outcome measures: maternal 
IL levels in the immediate postpartum 
period
According to GLM analysis, using a model including 
intensity of alcohol and tobacco use in the last 3 months 
before delivery, mode of delivery, and maternal ethnicity, 
IL-6 measures in the immediate postpartum period 
were significantly higher in mothers with a history of 
crack/cocaine use (25,160.05, 95%CI 10,958.15-
39,361.99) than in control mothers (8,902.14, 95%CI 
Cannabis Cases (n = 26) Controls (n = 26)
Daily/almost every day 2 (7.7) - -
Weekly 5 (19.2) - -
Monthly 2 (7.7) - -
Once or twice 1 (3.8) - -
Never 16 (61.5) - -
Presence of current psychopathology in mothers, n (%) Cases (n=41) Controls (n=96)
Suicide risk 13 (31.70) 9 (9.78) 0.002
Posttraumatic stress disorder*§ 4 (10.00) 0 (0.00) 0.007
Antisocial personality disorder* 9 (21.43) 0 (0.00) < 0.001
MINI positive for any diagnoses 25 (61.0) 32 (33.3) 0.005
Unadjusted UCB IL levels§ Cases (n = 45) Controls (n = 93)
IL-6 in UCB
Median (minimum and maximum) 2,013.95  (0-583,892.27)
737.61  
(0-29,649.70) 0.004




Median (minimum and maximum) 109.93  (0-2,445.83) 9.14 (0-1,016.84) < 0.001
Mean (SD) 335.62 (591.70) 47.41 (121.43)
Unadjusted IL levels at immediate postpartum, mothers§ Cases (n = 48) Controls (n = 83)
Maternal IL-6 levels









Median (minimum and maximum) 195.14  (0-34,305.03)
310.36  
(0-9,441.20) 0.12
Mean (SD) 1,215.63 (4,954.13)
1,105.25 
(1,894.63)
* Fisher’s exact test.
† Based on Alcohol, Smoking and Substance Involvement Screening Test (ASSIST).
‡ Mann-Whitney U test.
§ p-value for median comparisons only, Mann-Whitney U test.
ASSIST = Alcohol, Smoking and Substance Involvement Screening Test; IL = interleukin; IQ = intelligence quotient; SD = standard deviation; UCB = umbilical 
blood cord.
difference between sexes in the case group (Mann-
Whitney U), where median IL-6 was significantly higher 
in boys (median = 6,726.20; range = 177.63-583,892.27; 
interquartile range = 990.30-18,429.06; n = 19) than 
in girls (median = 856.92; range = 56.64-203,797.48; 
interquartile range = 597.13-3,017.68; n = 24; p = 0.022). 
Although the median IL-10 level was also higher in newborn 
boys with a history of crack/cocaine exposure in utero than 
in exposed girls (196.16 vs. 68.16), this difference did not 
attain statistical significance (p = 0.14). Interestingly, we 
found no significant differences for IL-10 (p = 0.42) or IL-6 
(p = 0.33) when analyzing the control newborns in isolation. 
Although the result for sex of newborns did not meet the 
statistical criterion for entry into the multivariate analysis, 
we conducted the same GLM for both IL-10 and IL-6 in UCB 
adding newborn sex as an additional variable. No major 
changes to the IL-6 model resulted. However, newborn 
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5,774.97-12,029.32, p = 0.007), as shown in Figure 3. 
Intensity of alcohol use and tobacco use and mode of 
delivery were also significant in the model (p = 0.010, 
0.001, and < 0.001, respectively). Univariate analysis 
found no difference in IL-10 levels between case 
and control groups expressed as median (minimum-
maximum) (195.14 [0-34,305.03] vs. 310.36 [0-
9,441.20] respectively; p = 0.12). The confounders 
entered into the model for IL-10 were mode of delivery, 
estimated IQ, and intensity of tobacco use in the last 3 
months before delivery. None of the variables attained 
significance, and there was no difference in adjusted 
mean IL-10 between exposed and non-exposed mothers 
(1,086.40 vs. 1,200.42 respectively, p = 0.83).
Discussion
This study analyzed early neurobiological markers 
involved in inflammatory activation in newborns with 
a history of crack/cocaine exposure in utero. These 
markers were measured at delivery, when the newborn 
has not yet been exposed to other stressors. We 
found a significant increase in inflammatory activation 
in newborns with a history of intrauterine crack/
cocaine exposure, as assessed both by IL-6 and IL-10 
measures; and this finding remained after adjusting for 
confounders. In pregnant women who reported crack/
cocaine use, inflammatory activation (measured by IL-6) 
was also observed, considering confounders. Among the 
exposed newborns, male newborns seemed particularly 
vulnerable to inflammatory activation. Arriving at an 
explanation for our findings is complex and may involve 
a variety of mechanisms that interact with each other.
Other studies have evaluated peripheral inflammatory 
markers in cocaine users, and have found a trend 
toward greater inflammatory activation.16,17 However, 
studies specifically investigating mother/newborn dyads 
exposed to crack/cocaine are scarce, limiting the scope 
for comparison of our findings. Cocaine may be linked 
with inflammation resulting from the neuronal damage 
or death that it causes.17 In terms of neuronal death, 
crack/cocaine would be more hazardous than snorted 
cocaine because of the byproducts of pyrolysis, which 
generates anhydroecgonine methyl ester.32 Cocaine 
administration increases levels of dopamine and its 
metabolites, resulting in exacerbated production of 
reactive oxygen species.33,34 Oxidative stress per se 
promotes inflammation,35 triggering generation of 
proinflammatory cytokines and chemokines. Additionally, 
cocaine has a vasoconstrictor effect on the uterine artery, 
resulting in fetal hypoxia and increased catecholamine 
release, thereby exposing the developing embryo/fetus 
Figure 1 - Adjusted mean IL-6 in the umbilical cord blood 
of newborns with a history of crack/cocaine exposure during 
pregnancy (EN; case group) compared to controls (NEN); 
mean adjusted for intensity of maternal alcohol, tobacco, and 
cannabis use in the last 3 months before delivery, maternal 
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Figure 2 - Adjusted mean IL-10 in the umbilical cord blood 
of newborns with a history of crack/cocaine exposure during 
pregnancy (EN) compared to controls (NEN); mean adjusted 
for intensity of maternal alcohol, tobacco, and cannabis use 
in the last 3 months before delivery, maternal ethnicity, 
presence of any maternal psychopathology, 5-minute Apgar 
score, newborn weight, maternal educational attainment, and 
maternal infectious diseases (HIV, syphilis, or hepatitis C).
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Figure 3 - IL-6 levels in the peripheral blood of women with 
a history of crack/cocaine use vs. control mothers. Mean IL-6 
adjusted for intensity of alcohol and tobacco use in the last 
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the developmental programming model and the 
telomere shortening phenomenon, with repercussions 
for generations to come.40,47-49 Knowing that exposure 
to cocaine alters corticostriatal gene expression,50 which 
also changes the stress response, we can expect these 
newborns to develop a more active warning system, 
leaving them vulnerable to addictive behavior. Although 
we did not assess cerebral morphology, studies have 
suggested an inverse association between IL-6 levels 
and hippocampal volume.51,52 These changes in the 
hippocampus may contribute to the cognitive deficits 
observed in infants, toddlers, and children exposed to 
cocaine in utero.53-57 In an animal model, gestational 
cocaine exposure induced significant changes to the 
electrophysiological properties of hippocampal neurons.58 
Intrauterine exposure to crack/cocaine could leave an 
immunological scar, making these infants vulnerable to 
physical and/or psychiatric disorders throughout life. 
This study helps to elucidate neurobiological mechanisms 
underlying these phenomena and contributes research 
topics of interest for future interventions. So far no 
evidence has been found to support treatments directed 
at the immune system from the psychiatric point of 
view. However, minocycline has been reported to reduce 
inflammatory activation in schizophrenic adults59 and 
agents that target inflammatory processes are being 
considered for the treatment of depression.60-62
The present study has certain limitations. We used 
two measures to assess deregulation of the immune 
system (IL-10 and IL-6), but other markers are available. 
However, much research on neuroinflammation has been 
based on changes in IL-6 and IL-10.63-66 Our sample 
comprised pregnant polydrug users. This increases 
the external validity of the study and, the data were 
adjusted for use of other substances in multivariate 
analysis. However, because of the size of the sample, 
the study does not have enough power to isolate all 
the factors that could influence inflammation response. 
Additionally, information about drug use was collected 
by retrospective interview, and is therefore subject to 
recall bias. We could not evaluate many of the crack/
cocaine using women at delivery time (lost to the 
sample); however, we made a careful chart review to 
analyze the loss profile, concluding that we probably 
lost the most severe cases (type II error). We did not 
measure maternal body mass index (BMI). While BMI is 
a good measure for the pre-gestational stage, it is not 
clinically useful when data collection takes place at the 
time of delivery, as in our study. Also, the method of 
blood collection did not account for time of day or time 
in a fasting state, which are factors that could influence 
cytokine values. Additionally, it is important to remember 
that we are dealing with a difficult-to-reach population of 
to a state of stress.20 This stress on the fetus would 
cause disturbances in cytokine homeostasis through 
activation of the HPA axis, sympathetic nervous system, 
and fibers of the vagus nerve.14,36 These factors may 
have contributed to the inflammatory activation seen 
in newborns with a history of crack/cocaine exposure 
in utero. Although our measures were “peripheral,” 
there is communication between the central nervous 
system, the hormonal system and the innate immune 
system.37,38 The repercussions of inflammatory activation 
on neurodevelopment, the HPA axis, and epigenetics 
have recently been discussed elsewhere.39,40 Our results 
corroborate findings reported by Glover,41 who stated 
that cytokines are potential mediators for explaining 
the behavioral and cognitive effects of prenatal stress 
on the fetus and child. Studies have demonstrated the 
role of proinflammatory cytokines in several disorders, 
including depression and anxiety, as well as their role 
in cognitive function. Abnormalities in immune function 
have been reported in neurodevelopmental disorders.40
We found no correlation between maternal and 
neonatal IL-6 and IL-10 levels, whether in inter-group 
or intra-group comparisons. In other words, our results 
show that the reactions of pregnant women and their 
newborns are different. For example, we did not find 
any difference in IL-10 levels in pregnant women, but 
we did detect a difference in UCB measures, even with a 
smaller sample size. Developmental changes in immune 
and neuroendocrine function mediate perception and 
physiology of stress with effects that last throughout 
life.40,41 It is to be expected that pregnant women who 
use crack/cocaine will exhibit different responses 
in comparison with their newborns, because of the 
accumulation of stressors to which they are exposed 
throughout the course of their lives, coupled with the need 
to adapt to these factors. Our study, for example, detected 
several other chronic stressors (some prior to pregnancy) 
in those who reported crack/cocaine use when compared 
to controls (Table 1). Our findings agree with previous 
studies reporting that gestational stress is associated 
with greater inflammatory activation,42-44 which places 
newborns in a more vulnerable position, either because 
of the intensity of activation or because of changes in 
IL-6 and IL-10 levels. Furthermore, boys with a history of 
crack/cocaine exposure in utero were significantly more 
likely to exhibit increased IL levels than girls. This finding 
is also in agreement with other studies.45,46
Thus, this study may contribute to the search for 
neurobiological markers of the future clinical and/
or neuropsychiatric repercussions of intrauterine 
crack/cocaine exposure demonstrated in previous 
research.1,3 These types of clinical changes, which 
persist into adulthood, have been understood through 
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women who received, for instance, zero or incomplete 
prenatal care. Finally, since this is a cross-sectional 
study, it cannot be used to establish causal relationships.
Conclusion
This study found elevated markers of inflammatory 
activation in the UCB of newborns with a history of 
crack/cocaine exposure in utero and in peripheral blood 
samples from their mothers when compared to non-
exposed controls. These changes can be regarded as 
neurobiological markers, which represent a link between 
neurodevelopmental and clinical changes. Confirmation 
of these findings in future studies could be used to 
support preventive intervention strategies that target 
the immune system of the newborn, perhaps improving 
prognosis as a result.
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